Strand's Precision Diagnostics: Transforming Canine Cancer Care with Advanced Genomic Insights

• Our client is a San Diego-based company specializing in canine cancer detection.
• The client sought to develop a non-invasive liquid biopsy NGS test for early canine cancer detection, focusing on variant discovery.
• Strand's team analyzed WES samples, developed tools, curated literature, compared human and canine variants, and created a breed classifier.
• Identified key canine cancer variants, developed a breed-sensitive classifier, and pinpointed critical genomic regions for the NGS panel.